Literature DB >> 23354794

Immunohistochemical expression of p16 in pleomorphic salivary adenoma.

Bassel Tarakji1, Kusai Baroudi, Shorouk Darwish, Salah Sakka, Salah Hanouneh.   

Abstract

OBJECTIVE: This study aimed to characterize alteration in the immunohistochemical expression of p16 in normal tissue of the salivary gland surrounding pleomorphic adenoma, and the tumor cells of pleomorphic adenomas. MATERIAL AND
METHOD: A selected series of 120 cases of pleomorphic adenomas were examined.
RESULTS: The results showed that p16 expression in non tumor duct cells was strong positive nuclear staining in 98 (81.6%) cases out of 120, while there were 20 (16.6%) with moderate staining, and 2 (1.6%) with weak staining in the components of normal tissue of the salivary gland surrounding pleomorphic adenoma. p16 expression in pleomorphic adenomas showed 71 (59.1%) cases with moderate nuclear staining in the duct cells, 45 (37.5%) cases with nuclear weak staining, and 4 (3.3%) cases with negative staining. p16 nuclear staining in myxochondroid tissue was identified in 4 (3.3%) cases with strong staining, 65 (54.1%) cases had moderate staining, and 51 (42.5%) cases had weak staining.
CONCLUSION: This study suggests alteration of p16 expression in pleomorphic adenomas. P16 might have a role in the development of pleomorphic adenoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354794     DOI: 10.5146/tjpath.2013.01145

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  2 in total

1.  P27 expression in pleomorphic salivary gland adenoma.

Authors:  Bassel Tarakji; Ayesha Umair; Mohammed Alsakran Altamimi; Saleh Nasser Azzeghaiby; Abla Sayed Mahmoud; Shourouk Darwish; Mohammad Zakaria Nassani; Nipun Ashok
Journal:  Contemp Oncol (Pozn)       Date:  2014-09-23

2.  P16 and HPV discordance in metastatic carcinoma of cervical lymph nodes of unknown primary.

Authors:  Alyssa Ralph; Andrew Meyer; Ronald Sirota; Arthur Hooberman
Journal:  Clin Case Rep       Date:  2015-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.